SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-008210
Filing Date
2018-11-01
Accepted
2018-11-01 06:25:59
Documents
58
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q syrs-20180930x10q.htm 10-Q 1577543
2 EX-31.1 syrs-20180930ex3112a795e.htm EX-31.1 10954
3 EX-31.2 syrs-20180930ex3120c1dcf.htm EX-31.2 11326
4 EX-32.1 syrs-20180930ex3218b2d87.htm EX-32.1 7450
5 EX-32.2 syrs-20180930ex3227e8ff7.htm EX-32.2 7291
  Complete submission text file 0001558370-18-008210.txt   5745400

Data Files

Seq Description Document Type Size
6 EX-101.INS syrs-20180930.xml EX-101.INS 1195256
7 EX-101.SCH syrs-20180930.xsd EX-101.SCH 42806
8 EX-101.CAL syrs-20180930_cal.xml EX-101.CAL 39974
9 EX-101.DEF syrs-20180930_def.xml EX-101.DEF 153912
10 EX-101.LAB syrs-20180930_lab.xml EX-101.LAB 382857
11 EX-101.PRE syrs-20180930_pre.xml EX-101.PRE 282033
Mailing Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37813 | Film No.: 181151897
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences